Pipeline

A novel approach to target inflammatory diseases

Using its proprietary technology platform, Inotrem is leveraging its extensive knowledge of the TREM-1 pathway biology to develop programs in several indications with inflammatory syndromes for which there is a major and today unsatisfied therapeutic need.